The history of the erectile dysfunction drug presents a challenging picture for shareholders. While the initial release generated massive gains, the expiration of its exclusive rights opened the avenue to cheaper https://bookmarkquotes.com/story21773229/sildenafil-and-the-pharmaceutical-industry-a-precarious-opportunity